<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">84414</article-id><article-id pub-id-type="doi">10.7554/eLife.84414</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>An herbal drug combination identified by knowledge graph alleviates the clinical symptoms of plasma cell mastitis patients: a nonrandomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-156274"><name><surname>Liu</surname><given-names>Caigang</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2083-235X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-298753"><name><surname>Yu</surname><given-names>Hong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-298569"><name><surname>Chen</surname><given-names>Guanglei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-298570"><name><surname>Yang</surname><given-names>Qichao</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-308087"><name><surname>Wang</surname><given-names>Zichu</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-254347"><name><surname>Niu</surname><given-names>Nan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-298572"><name><surname>Han</surname><given-names>Ling</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-298765"><name><surname>Zhao</surname><given-names>Dongyu</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-298764"><name><surname>Wang</surname><given-names>Manji</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-298766"><name><surname>Liu</surname><given-names>Yuanyuan</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-217314"><name><surname>Yang</surname><given-names>Yongliang</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0449-0599</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf5"/></contrib><aff id="aff1"><institution content-type="dept">Department of Oncology</institution>, <institution>Shengjing Hospital of China Medical University</institution>, <addr-line><named-content content-type="city">Shenyang</named-content></addr-line>, <country>China</country></aff><aff id="aff2"><institution content-type="dept">School of Bioengineering</institution>, <institution>Dalian University of Technology</institution>, <addr-line><named-content content-type="city">Dalian</named-content></addr-line>, <country>China</country></aff><aff id="aff3"><institution>China Resources Sanjiu Medical and Pharmaceutical Co, Ltd</institution>, <addr-line><named-content content-type="city">Shenzhen</named-content></addr-line>, <country>China</country></aff><aff id="aff4"><institution content-type="dept">International Cancer Institute</institution>, <institution>Peking University</institution>, <addr-line><named-content content-type="city">Beijing</named-content></addr-line>, <country>China</country></aff><aff id="aff5"><institution>Shanghai BeautMed Corporation</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff><aff id="aff6"><institution content-type="dept">Department of Biology</institution>, <institution>University of Copenhagen</institution>, <addr-line><named-content content-type="city">Copenhagen</named-content></addr-line>, <country>Denmark</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-190571"><name><surname>Iqbal</surname><given-names>Jameel</given-names></name><role>Reviewing editor</role><aff><institution>DaVita Labs</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>angel-s205@163.com</email> (CL);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>everbright99@foxmail.com</email> (YY);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>14</day><month>03</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e84414</elocation-id><history><date date-type="received"><day>24</day><month>10</month><year>2022</year></date><date date-type="accepted"><day>08</day><month>03</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Liu et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Liu et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-84414-v1.pdf"/><abstract><p><bold>Background:</bold> Plasma cell mastitis (PCM) is a nonbacterial breast inflammation with severe and intense clinical manifestation yet treatment methods for PCM are still rather limited. Although the mechanism of PCM remains unclear, mounting evidences suggest that the dysregulation of immune system is closely associated with the pathogenesis of PCM. Drug combinations or combination therapy could exert improved efficacy and reduced toxicity through hitting multiple discrete cellular targets.</p><p><bold>Methods:</bold> We have developed a knowledge graph architecture towards immunotherapy and systematic immunity that consists of herbal drug-target interactions with a novel scoring system to select drug combinations based on target-hitting rates and phenotype relativeness. To this end, we employed this knowledge graph to identify an herbal drug combination for PCM and we subsequently evaluated the efficacy of the herbal drug combination in clinical trial.</p><p><bold>Results:</bold> Our clinical data suggests that the herbal drug combination could significantly reduce the serum level of various inflammatory cytokines, downregulate serum IgA and IgG level, reduce the recurrence rate and reverse the clinical symptoms of PCM patients with improvements of general health status.</p><p><bold>Conclusions:</bold> In summary, we reported that an herbal drug combination identified by knowledge graph can alleviate the clinical symptoms of plasma cell mastitis patients. We demonstrated that the herbal drug combination holds great promise as an effective remedy for PCM, acting through the regulation of immunoinflammatory pathways and improvement of systematic immune level. In particular, the herbal drug combination could significantly reduce the recurrence rate of PCM, a major obstacle for PCM treatment. Our data suggests that the herbal drug combination is expected to feature prominently in future PCM treatment.</p><p><bold>Funding:</bold> Liu's lab was supported by grants from the Public Health Science and Technology Project of Shenyang (Grant: 22-321-32-18), Y. Yang's laboratory was supported by the National Natural Science Foundation of China (Grant: 81874301); the Fundamental Research Funds for Central University (Grant: DUT22YG122) and the Key Research project of 'be Recruited and be in Command' in Liaoning Province (2021JH1/10400050).</p><p><bold>Clinical trial number:</bold> ClinicalTrials.gov: NCT05530226.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81874301</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Yongliang</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81572609</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Caigang</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Caigang Liu, Senior editor, <italic>eLife</italic>.</p></fn><fn fn-type="conflict" id="conf3"><p>Ling Han, is an employee of China Resources Sanjiu Medical &amp; Pharmaceutical..</p></fn><fn fn-type="conflict" id="conf4"><p>Manji Wang, is an employee of Shanghai BeautMed Corporation..</p></fn><fn fn-type="conflict" id="conf5"><p>Yongliang Yang, Reviewing editor, <italic>eLife</italic>.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The protocol was approved by the Institutional Review Board (IRB) of the China Medical University (approval number: 2021PS024T). This study was registered with ClinicalTrials.gov: NCT05530226. All patients provided written informed consent.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Figure 1-3 are computational study and therefore no data have been generated for the manuscript. In addition, Figure 4 - Source Data, Figure 5 - Source Data,  Figure 6 - Source Data 1, Figure 6 - Source Data 2 and Figure 6 - Source Data 3 contain the numerical data used to generate the figures have been included in the manuscript.</p></sec><supplementary-material><ext-link xlink:href="elife-84414-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>